Preservica
GSK Selects Preservica Enterprise for its Corporate Archive, Ushering in a New Era of Digital Asset Resilience and Accessibility in Pharmaceuticals
BOSTON, MA and OXFORD, UK / ACCESSWIRE / January 30, 2024 / Preservica, a global leader in Active Digital Preservation™ archiving, is thrilled to announce GSK (GlaxoSmithKline), a multinational pharmaceutical and biotechnology company, has officially chosen Preservica as its Digital Preservation and archiving supplier for their Corporate Heritage Archives.
As a global leader in uniting science, technology and talent, GSK opted for Preservica's Enterprise edition with Active Digital Preservation™, ensuring not only the secure storage of historical records but also the continuous management, accessibility and protection of critical corporate governance and compliance documents in a way that goes beyond conventional archiving solutions.
The choice of Digital Preservation reflects a strategic decision to ensure the accessibility, integrity and longevity of these records. By leveraging Preservica, GSK not only fulfills its archival needs but also establishes a foundation to inform and protect the future of the business, offering valuable insights for strategic decision-making and ensuring a robust framework for regulatory compliance and brand continuity.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.GSK employee working in tuberculosis imaging laboratory at Tres Cantos site, Madrid
"After a comprehensive evaluation of preservation solutions, we confidently selected Preservica," said Jill Moretto, Senior Information Governance and Heritage Archive Manager. "Preservica automates our content migration workflows and also integrates seamlessly with our collections management system, Qi. Overall, it's simplifying our processes and eliminating duplicative work for the GSK Heritage team. This streamlined workflow is instrumental in documenting our contributions and legacy in health, science, industry, culture and the community, showcasing our impact on a global scale. Preservica completes GSK Heritage's core needs as a corporate archive. I'm so excited to use it to protect our legacy as we continue to get ahead of disease together."
Preservica Enterprise solution seamlessly integrates all essential elements for successful Digital Preservation, including public and secure access. The Enterprise edition not only meets but exceeds core requirements, offering a singular, integrated application that delivers comprehensive, scalable and fully compliant protection for critical long-term assets.
"This partnership stands as a testament to Preservica's commitment to advancing digital preservation standards across industries," said Preservica CEO, Mike Quinn. "Preservica is proud to contribute to the resilience and longevity of digital assets in an arena where historical data integrity directly influences advancements in healthcare and pharmaceutical breakthroughs."
The collaboration focuses on bolstering internal and external communications, as well as supporting marketing initiatives through the preservation of diverse file formats, including AV, TIFF, JPEG and standard office formats.
For more information on how Preservica is part of an international community of pharmaceutical institutions worldwide that are choosing Preservica as their trusted partner for Digital Preservation, visit preservica.com.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Find out more at gsk.com.
About Preservica
Preservica is transforming the way organizations around the world protect and future-proof critical long-term digital information. Available in the cloud (SaaS) or on-premise, our award-winning Active Digital Preservation™ archiving software has been designed from the ground up to tackle the unique challenges of ensuring digital information remains accessible and trustworthy over decades.
It's a proven solution that's trusted by thousands of businesses, archives, libraries, museums and government organizations around the world, including the UK National Archives, Texas State Library and Archives, MoMA, Yale and HSBC.
preservica.com
Twitter: @Preservica
LinkedIn: @Preservica
Media Contact:
Aleeza Goodman
York IE
aleeza@york.ie
SOURCE: Preservica
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom